Joint Pain Clinical Trial
Official title:
A Randomized, Placebo-controlled, Double-blind, Cross-Over Study to Evaluate the Efficacy of E-PR-01 on Activity Induced Joint Pain
This Clinical trial study for the effect of a product E-PR-01 will be studied for its ability to attain rapid pain relief in the individuals suffering from exercise-induced knee joint pain, as well as determine its sustained effect on pain reduction over a treatment period of five days.
The study is a randomized, double-blind, placebo controlled, cross-over study to explore the effect of a product E-PR-01 on joint pain. Approximately 50 participants aged between ≥ 20 and ≤ 60 years will be screened. At least 40 participants will be randomized, and the participants will be crossed over both the IP and placebo arms. A minimum of 32 participants must complete the study, after accounting for the screening failure and dropout /withdrawal rate of 20% each. The duration of each treatment for all the study participants will be 5 days, the washout period between each treatment period being 5 ± 2 days. The total study period from the first start of treatment visit, inclusive of the washout and treatment periods, is estimated to be 15 days. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04285112 -
SPRINT: Signature for Pain Recovery IN Teens
|
||
| Completed |
NCT04506411 -
Turmeric Efficacy for Mobility and Joint Function
|
N/A | |
| Terminated |
NCT00973141 -
A Dose-ranging Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Osteoarthritis-related Pain
|
Phase 2 | |
| Completed |
NCT04408560 -
Evaluation of the Efficacy of a Homeopathic Protocol in Patients With Non-metastatic Breast Cancer
|
N/A | |
| Completed |
NCT04150211 -
Effects of Exten(d) Supplementation on Training Ability in Recreational Runners
|
Phase 2 | |
| Completed |
NCT03209895 -
Study to Evaluate the Safety and Efficacy of a Proprietary "Joint Health" Dietary Supplement in Subjects With Joint and Connective Tissue Pain
|
N/A | |
| Withdrawn |
NCT01612728 -
Treatment for Joint Pains Due to Aromatase Inhibitor Therapy in Breast Cancer
|
Phase 2 | |
| Completed |
NCT00691678 -
Glucosamine and Chondroitin for Aromatase Inhibitor Induced Joint Symptoms in Women With Breast Cancer
|
Phase 2 | |
| Recruiting |
NCT05212259 -
Clinical Study to Evaluate the Effect of Different Doses of UC-II® Supplementation on the Range of Motion & Joint Discomfort in Healthy Subjects
|
N/A | |
| Recruiting |
NCT04182659 -
Long Term Efficacy of Neuronavigation Guided rTMS in Alleviating Gulf War Illness Related Headaches and Pain Symptoms
|
N/A | |
| Terminated |
NCT04712019 -
Evaluating Edema and Range of Motion Using Negative Pressure Therapy vs. Standard Surgical Dressing in Bilateral TKA
|
N/A | |
| Recruiting |
NCT06074744 -
Subsartorial Nerve Block and Femoral Nerve Block in Total Knee Arthroplasty
|
N/A | |
| Recruiting |
NCT00325845 -
Synvisc Injections for Lumbar Facet Joint Pain
|
Phase 3 | |
| Terminated |
NCT04872556 -
Evaluation of the Effect of Laser Acupuncture on Taxane Acute Pain Syndrome Patients
|
N/A | |
| Active, not recruiting |
NCT03865992 -
Curcumin in Reducing Joint Pain in Breast Cancer Survivors With Aromatase Inhibitor-Induced Joint Disease
|
N/A | |
| Recruiting |
NCT05282992 -
NAtive Collagen Type II In Healthy VoluntEers With Joint Discomfort
|
N/A | |
| Recruiting |
NCT04994249 -
Diagnostic and Prognostic Biomarkers for High-impact Chronic Pain: Development and Validation
|
||
| Completed |
NCT01509079 -
Vitamin D3 Effects on Musculoskeletal Symptoms With Use of Aromatase Inhibitors
|
Phase 2 | |
| Completed |
NCT04764110 -
Short-term Impact of Cyplexinol® on Self-reported Joint Pain
|
N/A | |
| Not yet recruiting |
NCT06444867 -
A Study to Evaluate Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Dose of LEO 158968
|
Phase 1 |